Population
3,805 cancer patients with acute venous thromboembolism (VTE) enrolled in the RIETE registry
Design
Cohort
Follow-up
3 months
Authors
Loading...
May aid recurrence risk stratification in cancer-associated VTE; leaves open whether targeted interventions improve outcomes.
Specific clinical variables available at entry, such as age, time from cancer diagnosis, immobility, and renal function, can identify cancer patients with VTE at high risk for recurrence or major bleeding.
Trujillo‐Santos et al. (2008) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: